Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. - Wikidata - wikimedia - TriplyDB

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

http://www.wikidata.org/entity/Q34007084

about

Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication Conformation of the dileucine-based sorting motif in HIV-1 Nef revealed by intermolecular domain assembly How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4 In vivo analysis of highly conserved Nef activities in HIV-1 replication and pathogenesis.Generation and characterization of a defective HIV-1 Virus as an immunogen for a therapeutic vaccine.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.Myristoylation: An Important Protein Modification in the Immune Response High viral fitness during acute HIV-1 infection.Neutron reflectometry study of the conformation of HIV Nef bound to lipid membranes Self-association of the Lentivirus protein, Nef Trans-cellular introduction of HIV-1 protein Nef induces pathogenic response in Caenorhabditis elegans.CD4 and MHC class 1 down-modulation activities of nef alleles from brain- and lymphoid tissue-derived primary HIV-1 isolates.In vivo analysis of Nef's role in HIV-1 replication, systemic T cell activation and CD4(+) T cell loss.Nef functions in BLT mice to enhance HIV-1 replication and deplete CD4+CD8+ thymocytes.Compartmentalization of the gut viral reservoir in HIV-1 infected patients.Lipid metabolism in patients infected with Nef-deficient HIV-1 strain.Dual role of autophagy in HIV-1 replication and pathogenesis Dysregulation of autophagy by HIV-1 Nef in human astrocytes.Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.Functional characterization of the human immunodeficiency virus type 1 Nef acidic domain.HIV-1 Nef: at the crossroads Determinants in HIV-1 Nef for enhancement of virus replication and depletion of CD4+ T lymphocytes in human lymphoid tissue ex vivo Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.Mechanisms of HIV-1 Nef function and intracellular signaling.High levels of anti-Nef antibodies may prevent AIDS disease progression in vertically HIV-1-infected infants.HIV Nef- and Notch1-dependent Endocytosis of ADAM17 Induces Vesicular TNF Secretion in Chronic HIV Infection The Nef-infectivity enigma: mechanisms of enhanced lentiviral infection.Contributions of HIV-1 Nef to immune dysregulation in HIV-infected patients: a therapeutic target?Nef-mediated enhancement of cellular activation and human immunodeficiency virus type 1 replication in primary T cells is dependent on association with p21-activated kinase 2.HIV-1 Nef: Taking Control of Protein Trafficking.Modulation of HIV pathogenesis and T-cell signaling by HIV-1 Nef Human immunodeficiency virus type 1 Nef incorporation into virions does not increase infectivity Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.Remodeling of HIV-1 Nef Structure by Src-Family Kinase Binding.Small molecule CXCR4 antagonists block the HIV-1 Nef/CXCR4 axis and selectively initiate the apoptotic program in breast cancer cells.

P2860

Q26851152-B3EB7AC7-F728-47C7-8C51-54D83881551C Q27497968-65459FC6-AACB-4525-BEF5-DB9DD9DD8657 Q27667185-8C9A70C3-0C52-445D-8A9B-8C44099A07E7 Q27681494-D88BD0B7-68A9-4C31-BC5E-29B6B101D08A Q30009533-7F3A45C5-6BB2-42A7-86D2-1B4BE9A5D289 Q31106756-E5D8DEE2-B181-47F3-9A4B-4455C53E4998 Q33753132-D249F747-F817-4B1D-9D0D-3664AF71E98C Q33827771-683ACDB7-B867-4585-B50B-138CE497564D Q33857561-08ED30BC-6840-4CEA-B034-F1C3306C7681 Q34115280-DC8C1A66-380C-4FDB-A8C7-26541D71F17A Q34134785-1B1E4397-C664-45E2-9023-A89C72A934BF Q34203170-AB5C1F98-3A70-44B9-A7D5-6B0602F25FD1 Q34403732-417C6B27-D3A8-48AD-9F8F-A5B9358B1C5B Q35400103-173A335B-59D5-4873-8F7E-19F65B08CB9D Q35848314-31CDDF04-ED11-4C86-9766-74859F62F782 Q36112824-9948563B-9E6E-43DD-8E3C-16753C11F409 Q36412750-000289AB-1911-4F97-B896-70FA8CDB641D Q36421895-F36DE31C-3AC9-412D-93B3-99CE1CCDA390 Q36445102-20CEAE83-CDE2-42BD-8984-E7142EEB975A Q36780644-3FB6B5CF-34E2-4F94-9556-F9DD02158936 Q36796376-19132965-79D1-4605-A004-68DA1C6666A3 Q36898851-D88AA9AC-7527-4339-8520-4285707EE6FE Q36926697-9CF051F7-8AE8-4088-9EB1-EBBEAA89C786 Q37072999-E477ACC7-1C0F-4735-99D1-F403803F95F8 Q37078512-C6E2A023-6CCF-4610-8AB1-6937350522DF Q37183848-D0E56BE2-14AC-45D8-9D3D-95CF77044630 Q37590720-4A09C4CB-09EA-4334-A495-51733C6106BD Q37604918-E964B9C7-1267-482B-9471-32E1B5E6AA60 Q37959034-36E4F75E-2DF8-4290-87FA-96D9D9BD538B Q38130717-39375754-C5CC-401E-914B-217560B531BC Q38356666-416DDCB6-69E5-4B41-B8A3-7445C3FE7981 Q38830464-14A41F7B-2851-4CEC-ABBD-034FD22AEB58 Q39577894-51A3F238-05D4-4F58-9DB0-0316AABAB224 Q42125314-70C113F1-724E-481F-B484-3603D70AF11D Q42130441-A461949E-D620-4F68-A22A-07CBEC2BFBA2 Q47273958-19AD5149-66B9-4DC7-AC55-9BEC0B7AB60B Q54230682-044377CE-F57E-45A8-9256-E2FED03B05B7

P2860

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

http://www.wikidata.org/entity/Q34007084

description

2007 nî lūn-bûn

@nan

2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@ast

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@en

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@nl

type

label

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@ast

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@en

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@nl

prefLabel

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@ast

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@en

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@nl

P1433

Q34007084-0043480E-D7DC-4F9C-A7B0-E5F678F0D90E

P1476

Q34007084-AD7B0DC3-4B39-4716-9DEE-450AD4A0ACAA

P2093

Q34007084-01F28ECC-F109-4151-94E3-02A83FBA5149

Q34007084-0237536A-0520-4DFC-9299-198A6C028FAA

Q34007084-31445021-493B-4348-BE0D-F66BCE8B3A2E

Q34007084-348640F3-4648-42DB-AFF8-9E556771B031

Q34007084-65DE1015-D70C-4D65-8592-BE6C53519020

Q34007084-70B433C3-1F09-4906-97DD-0475B7C86AC1

Q34007084-759DE73C-21F1-4CD0-B50F-7E24AE987C7B

Q34007084-8C60347B-E4EC-48A5-86D7-87DF0B150FF6

Q34007084-A34B9F0F-7F1C-49A2-A711-BAD1CA9842E4

Q34007084-A658FF6A-4528-444F-9A79-AD2F4E7FD135

P2860

Q34007084-00610FF5-D400-46DC-A380-1A89897E12D6

Q34007084-018369D4-AA1C-464C-B4AC-42D729EEF822

Q34007084-06A53529-4419-45D9-B2EF-16457C711172

Q34007084-0C44015E-B1A3-4ED4-935B-4E9E307BB6A3

Q34007084-0C5D7F9B-ACB7-4C86-BD6A-A5ADBDCEC923

Q34007084-0D6214B6-1667-4931-B1F0-5AB21C916AC3

Q34007084-103A692B-5303-41AA-ABF0-B19513A36A18

Q34007084-1479405F-ACEA-4E25-B4B1-22C1ABF58DF2

Q34007084-24655798-3AF5-4247-99E4-0B5461985724

Q34007084-254B60CD-59FE-466D-ABCA-C5B979FDD26E

P2888

Q34007084-572F72D7-2CCF-4B05-A13E-D90A6ACA5C7C

P304

Q34007084-6AF21958-A96E-41A2-A0F5-CA5C61D12609

P31

Q34007084-FAE89D35-9269-42F7-B62B-FDEC060BA2C4

P356

Q34007084-4B60585F-C009-4B64-8B69-E66DD75E8DEF

P478

Q34007084-263AFC76-3CB8-42F9-94F5-C382A9311127

P50

Q34007084-2B5506B1-1FD5-4449-9414-A825F8812E3C

Q34007084-9618104F-32E1-4001-A081-279105BDA7F1

Q34007084-98EF7089-D2FC-432A-8E83-2914D0E7F6D5

Q34007084-E3709668-C5F4-4203-88BB-AC4F2075396A

P577

Q34007084-ABD3E413-A078-4B2C-ADB0-68D3010E70C4

P5875

Q34007084-A39A202A-2FD6-47F7-B2EB-58A5E13CF2B0

P6179

Q34007084-D592DA8E-81E1-4868-99B4-33D541436E97

P698

Q34007084-2D3D2FCD-FDB7-453F-B4A7-53355E8EFFF5

P932

Q34007084-22E8B72A-8FA6-466A-BA95-6FF7A7E44C4F

P356

P1433

P1476

Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.

@en

P2093

Dale A McPhee

http://www.w3.org/2001/XMLSchema#string

Dana Gabuzda

http://www.w3.org/2001/XMLSchema#string

Erin Verity

http://www.w3.org/2001/XMLSchema#string

Jennifer Learmont

http://www.w3.org/2001/XMLSchema#string

John J Zaunders

http://www.w3.org/2001/XMLSchema#string

John Mills

http://www.w3.org/2001/XMLSchema#string

John S Sullivan

http://www.w3.org/2001/XMLSchema#string

Melissa J Churchill

http://www.w3.org/2001/XMLSchema#string

Paul R Gorry

http://www.w3.org/2001/XMLSchema#string

Steven L Wesselingh

http://www.w3.org/2001/XMLSchema#string

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1

Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group.

A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames.

Immunopathogenesis and immunotherapy in AIDS virus infections

Influence of host genes on HIV-1 disease progression

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection

Correlation between immunologic responses to a recombinant glycoprotein 120 vaccine and incidence of HIV-1 infection in a phase 3 HIV-1 preventive vaccine trial

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

P2888

P304

66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1742-4690-4-66

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Sharon R. Lewin

Anthony L. Cunningham

P577

2007-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5956208

http://www.w3.org/2001/XMLSchema#string

P6179

1018351633

http://www.w3.org/2001/XMLSchema#string

P698

17888184

http://www.w3.org/2001/XMLSchema#string

P932

2075523

http://www.w3.org/2001/XMLSchema#string